Management of Hypophosphatemia

Initial Diagnostic Approach

The first priority is to determine whether hypophosphatemia represents renal phosphate wasting by calculating fractional excretion of phosphate or TmP/GFR from the urinalysis, and if elevated (>15%), proceed with a systematic diagnostic workup to identify the underlying cause before initiating treatment 1, 2, 3
Calculate TmP/GFR using spot urine phosphate, creatinine, and serum phosphate and creatinine levels to assess for renal phosphate wasting 1, 2
Measure urinary calcium excretion to distinguish between different causes of renal phosphate wasting 1, 3

Rule out generalized proximal tubular dysfunction (Fanconi syndrome) by checking for metabolic acidosis, glucosuria, aminoaciduria, and low molecular weight proteinuria 1, 3
If these are present, the diagnosis is not isolated renal phosphate wasting but rather a more complex tubular disorder requiring different management 1, 3
Non-suppressed or elevated FGF23 with hypophosphatemia suggests FGF23-mediated disorders, while suppressed FGF23 indicates primary renal tubular defects 1, 3

In children with confirmed X-linked hypophosphatemia, start oral phosphate at 20-60 mg/kg/day of elemental phosphorus divided into 4-6 doses daily, and combine with active vitamin D 4, 5
In adults with symptomatic disease, use substantially lower doses of 750-1,600 mg/day elemental phosphorus, and active vitamin D 6
Treatment is recommended only for symptomatic patients with musculoskeletal pain, pseudofractures, dental issues, or elevated bone-specific alkaline phosphatase 4, 6

Monitor serum phosphate, calcium, alkaline phosphatase, and PTH levels regularly to guide dose adjustments and prevent complications 2, 5
Monitor urinary calcium excretion to prevent nephrocalcinosis, and keep calciuria within normal range 4, 5
Watch for secondary hyperparathyroidism, and if PTH rises, increase active vitamin D and/or decrease phosphate dose 4